Genomic Profiling of Chronic Myelogenous Leukemia: Basic and Clinical Approach

Chronic myeloid leukemia (CML) is a hematological stem cell cancer driven by BCR-ABL1 fusion protein. We review the previous and recent evidence on the significance of CML in diagnostic and clinic management. The technical monitoring of BCR-ABL1 with quantitative real time-PCR has been used in assessing patient outcome. The cytogenetic mark of CML is Philadelphia chromosome, that is formed by reciprocal chromosomal translocations between human chromosome 9 and 22, t(9:22) (q³⁴:q¹¹). It makes a BCR-ABL1 fusion protein with an anomaly tyrosine kinase activity that promotes the characteristic proliferation of progenitor cells in CML and acute lymphoblastic lymphoma. The targeting of BCR-ABL1 fusion kinase is the first novel paradigm of molecularly targeted curing.

Rare chromosome structural aberration characterizing oncology malignancy

Ring chromosome aberration are rare abnormality potentially involving any chromosome in patients diagnosing in Oncology. The present review and case study has focused on the ring chromosome associated with oncology malignancies. An electronic peer review article search was performed systematically to obtain relevant literature with the CINAHL, Google scholar, and Pub Med databases. The keywords included marker, abnormalities, structural, Ring chromosome. The inclusion criteria for the review were that the documents were original quantitative research and published in English. This was also initiated using Medline, Mitelman database [http:/cgap.nci.nih.gov/Chromosomes/Mitelman], Danish cytogenetic register and other pertinent web references on ring chromosomes in Oncology malignancies. Articles that were not directly relevant to the present objective were excluded. Also the un-stimulated bone marrow specimen of present case manipulated with Methotrexate cells culture synchronization and finally was treated by GTG-banding technique. Ring chromosome was observed in 10% of the total cells. Cytogenetic analysis demonstrated apparently ring [15] 46, XY, r[15] karyotype. The clinical findings revealed history of nausea, loss of appetite, diarrhea, night sweats, and a weight loss, anemia and diagnosed as accelerated CML. Our finding adds to the spectrum of both morphology and genetic rearrangements in oncology malignancies. Additional future analyses in similar subject will be necessary to draw firm conclusions

[Resistance of Bifidobacterium sp. isolated from Iranian subjects to simulated gastric juice and bile salt]

Bifidobacteria are one of the most important probiotic bacteria and their benefits have been known since many years ago. Probiotic organisms are required to be safe, viable and metabolically active within the gastrointestinal tract and to show enough resistance against bile and gastric juice. In this research, the ability of growth and survival of 42 strains, isolated from Iranian subjects, were studied in MRS3 containing 0, 0.25, 0.5, 1 and 2% of bile salts and simulated gastric juice with pH 3. The cultured strains were incubated under anaerobic condition and at 37°C for 48 h and then the survival/growth rates were examined at 3, 6, 12 and 24 hrs. The results demonstrated that some strains had significantly high tolerance against bile salts and simulated gastric juice. The strains with high tolerance are suggested as Iranian strains for future work especially in preparing Iranian starter and bifidus products

[Identification of Bifidobacterium strains isolated from fecal samples of some Iranian subjects using 16SrRNA gene sequence analysis and PCR-based gene specific primers]

For the first time in Iran 40 strains of Bifidobacterium were isolated from faces of Iranian subjects. By using phenotypic tests, 18 isolates were identified as Bifidobacterium longum, 10 as Bifidobacterium bifidum and 1 as Bifidobacterium catenolatum. In order to validate these results and also to identify other isolates that had not been identified by phenotypic tests, 2 methods of PCR with genus-specific primers of Bif164f and Bif601r and 16SrRNA gene sequence analysis were applied. Results of PCR confirmed the obtained phenotypic identifications. Moreover by this method the 8 remaining strains were identified as Bifidobacterium species. Using sequencing 16SrRNA gene, 5 B.Longum strains were identified that had different fermentation pattern from B.Longum. Some new ribose negative Bifidobacterium longum strains were also identified. The obtained results present new strains of Bifidobacterium longum

[Identification of Bifidobacterium strains isolated from fecal samples of some Iranian subjects using 16 SrRNA gene sequence analysis and PCR-based gene specific primers]

For the first time in Iran 40 strains of Bifidobacterium were isolated from feces of Iranian subjects. By using phenotypic tests, 18 isolates were identified as Bifidobacterium longum, 10 as Bifidobacterium bifidum and one as Bifidobacterium catenolatum. In order to validate these results and also to identify other isolates that had not been identified by phenotypic tests, two methods of PCR with genus-specific primers of Bif164f and Bif601r and 16SrRNA gene sequence analysis were applied. Results of PCR confirmed the obtained phenotypic identifications. Moreover by this method the 8 remaining strains were identified as Bifidobacterium species. Using sequencing 16 SrRNA gene, 5 B. longum strains were identified that had different fermentation pattern from B. longum. Some new ribose negative Bifidobacterium longum strains were also identified. The obtained results present new strains of Bifidobacterium longum

Primary diffuse lymphomatous polyposis of the gastrointestinal tract

A rare case of diffuse lymphomatous polyposis of the gastrointestinal tract is reported in which the patient presented with abdominal pain, weight loss and bloody diarrhea. X-rays revealed multiple polyps involving the stomach, small intestine and colon. Biopsies confirmed the diagnosis of lymphomatous polyposis. The duration of symptoms and signs was 3 months. Diffuse lymphomatous polyposis of the gastrointestinal tract is a distinct entity, separated from diffuse gastrointestinal lymphoma or Mediterranean-type lymphoma